Ellex to begin sales of SLT technology in US
Ellex Medical Lasers will begin U.S. distribution of its proprietary selective laser trabeculoplasty technology immediately, according to a news release.
The launch comes after the expiration of a patent that prevented sales of the technology in the United States.
A patent held by Massachusetts General Hospital prevented Ellex from selling the device within the United States. The company has a 40% market share internationally, Ellex CEO Tom Spurling said in the release.